Bilastine is Strongly Preferred Over Diphenhydramine
For allergic conditions, bilastine (a second-generation H1-antihistamine) should be used instead of diphenhydramine (a first-generation H1-antihistamine) due to superior safety profile with equivalent efficacy. Second-generation antihistamines are generally preferred over first-generation agents for treating allergic rhinitis and urticaria because they have minimal to no sedation, performance impairment, or anticholinergic effects 1.
Key Differences
Sedation and CNS Effects
Diphenhydramine causes significant sedation and performance impairment that patients often don't subjectively perceive, making it dangerous for activities requiring alertness 1. Drivers taking first-generation antihistamines like diphenhydramine are 1.5 times more likely to be responsible for fatal automobile accidents 1. Workers experience impaired productivity and increased occupational accidents 1. In children, diphenhydramine is associated with impaired learning and school performance, and can paradoxically cause CNS stimulation 1.
Bilastine causes no sedation at recommended doses and does not cross the blood-brain barrier due to P-glycoprotein efflux 2, 3. It does not impair driving performance, does not enhance alcohol's CNS effects, and shows no interaction with CNS sedatives like lorazepam 2, 3.
Anticholinergic Effects
Diphenhydramine produces significant anticholinergic effects including:
- Dry mouth and eyes
- Constipation
- Urinary retention
- Increased risk of narrow-angle glaucoma
- Falls and fractures in older adults 1
Bilastine has no anticholinergic effects due to its high selectivity for H1-receptors with no affinity for other receptors 2, 3.
Special Populations
Older adults are particularly vulnerable to diphenhydramine's adverse effects, with increased risk of psychomotor impairment, falls, fractures, subdural hematomas, and complications from anticholinergic effects, especially with comorbidities like benign prostatic hypertrophy or cognitive impairment 1. Extra caution is warranted in this population 1.
Children are at risk for paradoxical CNS stimulation with diphenhydramine and impaired learning 1. Recent evidence suggests diphenhydramine poses a greater public health hazard in children and should be restricted 4.
Indications and Efficacy
Both agents are indicated for:
- Allergic rhinitis
- Urticaria
- Allergic conjunctivitis
Bilastine demonstrates equivalent or superior efficacy to other second-generation antihistamines for allergic rhinoconjunctivitis and urticaria with rapid onset and 24-hour duration 3, 5. In refractory chronic spontaneous urticaria, switching to standard-dose bilastine 20 mg showed non-inferiority to doubling the dose of other H1-antihistamines 5.
Dosing
- Diphenhydramine: 25-50 mg every 4-6 hours (multiple daily doses required) 6
- Bilastine: 20 mg once daily 2, 3, 5
Drug Interactions and Metabolism
Diphenhydramine interacts with alcohol, sedatives, hypnotics, and antidepressants, significantly enhancing performance impairment 1. The FDA label warns against concurrent use 6.
Bilastine undergoes negligible hepatic metabolism and has no cytochrome P450 interactions 2, 3. It does not interact with alcohol or CNS depressants 2.
Contraindications and Warnings
Diphenhydramine should be used with caution or avoided in patients with:
- Chronic bronchitis or breathing problems
- Glaucoma
- Enlarged prostate/urinary retention
- Elderly patients
- Those operating machinery or driving 6
Before prescribing diphenhydramine, physicians must ensure patients understand the potential for adverse effects and availability of safer alternatives 1.
Clinical Pitfalls to Avoid
Do not use the AM/PM dosing strategy (second-generation antihistamine in morning, first-generation at bedtime) to reduce costs. Diphenhydramine taken at bedtime still causes significant daytime drowsiness and performance impairment due to prolonged plasma half-lives and persistent end-organ effects 1.
Performance impairment can exist without subjective awareness of drowsiness with diphenhydramine—patients may deny sedation while objectively impaired 1.
Limited Role for Diphenhydramine
The only potential advantage of diphenhydramine is intentional sedation for sleep induction or reduction of rhinorrhea via anticholinergic effects 1. However, for rhinorrhea, intranasal ipratropium is preferred as it lacks sedation and performance impairment 1. For acute insomnia in adults, diphenhydramine may be considered as an over-the-counter option 7, though this is distinct from its use for allergic conditions.
For anaphylaxis, neither diphenhydramine nor bilastine should replace epinephrine as first-line treatment—antihistamines are adjunctive only, with onset too slow (30-120 minutes orally) and lacking vasoconstrictive/bronchodilatory properties 8.
Bottom Line
Bilastine offers equivalent efficacy to diphenhydramine for allergic conditions with dramatically superior safety, including no sedation, no performance impairment, no anticholinergic effects, no drug interactions, and once-daily dosing 2, 3, 5. Given that diphenhydramine remains available in over 300 formulations despite its problematic therapeutic ratio, recent expert opinion suggests it should no longer be widely prescribed or readily available over-the-counter 4.